Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway

Exp Cell Res. 2020 May 15;390(2):111928. doi: 10.1016/j.yexcr.2020.111928. Epub 2020 Mar 7.

Abstract

Podocyte injury leads to impaired filtration barrier function of the kidney that underlies the pathophysiology of idiopathic nephrotic syndrome (INS), the most common NS occurring in children. The heat shock protein 90 (Hsp90) is involved in the regulation of apoptosis in a variety of cell types, however, little is known about its role in podocytes and whether it associated with NS. Here, we show that Hsp90 is upregulated in glomeruli podocytes from mice with adriamycin (ADR)-induced nephropathy, and that it is also upregulated in an immortalized podocyte cell line treated with ADR in vitro, together suggesting an association of Hsp90 upregulation in podocytes with NS pathogenesis. Functionally, Hsp90 inhibition with PU-H71 aggravates ADR-induced podocyte apoptosis and worsens the impairment of filtration barrier function. Mechanistically, Hsp90 inhibition with PU-H71 enhances the activation of intrinsic apoptotic pathway, and moreover, blockade of podocyte apoptosis with zVAD-fmk (aVAD), a pan-caspase inhibitor, abrogates effects of Hsp90 inhibition on filtration barrier function of ADR-treated podocytes, thus demonstrating that Hsp90 inhibition aggravates ADR-induced podocyte injury through intrinsic apoptosis pathway. In sum, this study reveals a detrimental role of Hsp90 inhibition in podocyte injury, which may offer it as a potential therapeutic target in NS therapy.

Keywords: Adriamycin; Filtration barrier function; Hsp90; Intrinsic apoptosis pathway; PU-H71; Podocyte injury.

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Benzodioxoles / pharmacology
  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Caspase 9 / genetics
  • Caspase 9 / metabolism
  • Cell Line
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Doxorubicin / administration & dosage*
  • Gene Expression Regulation
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • HSP90 Heat-Shock Proteins / genetics*
  • HSP90 Heat-Shock Proteins / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Nephrotic Syndrome / chemically induced
  • Nephrotic Syndrome / genetics*
  • Nephrotic Syndrome / metabolism
  • Nephrotic Syndrome / pathology
  • Podocytes / drug effects*
  • Podocytes / metabolism
  • Podocytes / pathology
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Purines / pharmacology
  • Signal Transduction
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism

Substances

  • Amino Acid Chloromethyl Ketones
  • Antibiotics, Antineoplastic
  • Bax protein, mouse
  • Benzodioxoles
  • HSP90 Heat-Shock Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Purines
  • bcl-2-Associated X Protein
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • 9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-
  • Bcl2 protein, mouse
  • Doxorubicin
  • Casp3 protein, mouse
  • Casp9 protein, mouse
  • Caspase 3
  • Caspase 9

Supplementary concepts

  • Nephrosis, congenital